GLENMARK.NS - Glenmark Pharmaceuticals Limited

NSE - NSE Real Time Price. Currency in INR

Glenmark Pharmaceuticals Limited

Glenmark House
B.D. Sawant Marg
Mumbai 400099
India
91 22 4018 9999
http://www.glenmarkpharma.com

SectorHealthcare
IndustryDrugs - Generic
Full Time Employees13,000

Key Executives

NameTitlePayExercisedAge
Mr. Glenn Mario SaldanhaChairman, MD & CEO141MN/A47
Mr. P. GaneshPres & Global CFO15.65MN/AN/A
Mr. Harish KuberCompliance Officer & Company Sec.390kN/AN/A
Mrs. Cherylann Maria Pinto B.PharmExec. Director of Corp. Affairs & Exec. Director38.76MN/A50
Dr. Fred Grossman D.O., FAPAPres & Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its products under development comprise GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 8383 for multiple cancers; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; GSP 301 for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications. The company was founded in 1977 and is headquartered in Mumbai, India.

Corporate Governance

Glenmark Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.